BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 23 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,051 | -42.0% | 30,127 | 0.0% | 0.00% | – |
| Q2 2023 | $20,788 | -91.3% | 30,127 | 0.0% | 0.00% | – |
| Q1 2023 | $237,702 | +519.2% | 30,127 | -29.4% | 0.00% | – |
| Q4 2022 | $38,388 | +66.9% | 42,654 | +100.0% | 0.00% | – |
| Q3 2022 | $23,000 | -11.5% | 21,327 | 0.0% | 0.00% | – |
| Q2 2022 | $26,000 | -48.0% | 21,327 | 0.0% | 0.00% | – |
| Q1 2022 | $50,000 | -24.2% | 21,327 | 0.0% | 0.00% | – |
| Q4 2021 | $66,000 | -24.1% | 21,327 | 0.0% | 0.00% | – |
| Q3 2021 | $87,000 | -14.7% | 21,327 | +1.4% | 0.00% | – |
| Q2 2021 | $102,000 | -65.5% | 21,027 | -63.1% | 0.00% | – |
| Q1 2021 | $296,000 | -44.3% | 56,996 | -28.4% | 0.00% | – |
| Q4 2020 | $531,000 | -11.6% | 79,577 | +34.7% | 0.00% | – |
| Q3 2020 | $601,000 | +48.4% | 59,077 | +82.9% | 0.00% | – |
| Q2 2020 | $405,000 | – | 32,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFS Partners, LLC | 6,000 | $2,386 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 383,178 | $152 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 113,911 | $45,291 | 0.00% |
| OSAIC HOLDINGS, INC. | 557 | $221 | 0.00% |
| US BANCORP \DE\ | 1,221 | $485 | 0.00% |
| WELLS FARGO & COMPANY/MN | 180,066 | $71,594 | 0.00% |
| NORTHERN TRUST CORP | 30,251 | $12,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,656 | $38,262 | 0.00% |